A Growth & Income Investment JP Morgan Healthcare Conference - - PowerPoint PPT Presentation

▶
a growth amp income investment
SMART_READER_LITE
LIVE PREVIEW

A Growth & Income Investment JP Morgan Healthcare Conference - - PowerPoint PPT Presentation

Nov 14, 2023 159 likes •323 views

ABBOTT A Growth & Income Investment JP Morgan Healthcare Conference January 11, 2016 Brian Yoor, Senior Vice President, Finance and Chief Financial Officer 1 FORWARD LOOKING STATEMENT Some statements in this presentation may be

slide-1
SLIDE 1

1

A Growth & Income Investment

ABBOTT

JP Morgan Healthcare Conference January 11, 2016 Brian Yoor, Senior Vice President, Finance and Chief Financial Officer

slide-2
SLIDE 2

Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward- looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott’s operations are discussed in Item 1A, “Risk Factors,’’ to our Annual Report on Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2014, and in the interim reports filed on Form 10-Q for subsequent quarterly periods, and are incorporated by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

FORWARD LOOKING STATEMENT

2

slide-3
SLIDE 3

3

TOP-TIER GROWTH & INCOME INVESTMENT

Relevance

Leadership positions in businesses that are aligned with major trends and the broader global environment

Balance

Well-balanced diversity across

  • ur businesses,

geographies, and mix of payers

Global Presence

One of the most globalized healthcare companies with strong positions in both developed and emerging markets

Performance

Top-tier growth, steady margin expansion, strong cash flow, increasing returns to shareholders

slide-4
SLIDE 4

LEADING WITH SOLUTIONS ACROSS THE SPECTRUM OF HEALTH

#1 worldwide in adult nutrition #1 in U.S. pediatric nutrition World’s 1st bioresorbable scaffold World’s leading mitral valve repair device #1 in LASIK; #2 in cataract #2 Pharma Co. in India Top 10 Pharma Co. in Latin America and Russia #1 in blood screening Leading diagnostics platforms

4

slide-5
SLIDE 5

ALIGNED WITH TRENDS

Growth in emerging markets Investing in health care Emerging middle class Aging population globally

5

slide-6
SLIDE 6

6

Source: HBR ‘Prospects for Em erging Markets Aren’t as Bad as You’ve Heard’ (12/ 3/ 20 15) Source: World Health Organization, BMI Research and Haver

ALIGNED WITH TRENDS

slide-7
SLIDE 7

MEETING GROWING HEALTH NEEDS IN DEVELOPED AND DEVELOPING MARKETS

50%

OF SALES IN EMERGING MARKETS

50%

OF SALES DIRECTLY TO CONSUMERS

7

slide-8
SLIDE 8

8

OUR GLOBAL IDENTITY

  • life. to the fullest.
  • Build a highly recognizable brand
  • Our customer base is increasingly

consumer-facing

  • Connect with the people who use our

products

  • Cover the entire spectrum of care
slide-9
SLIDE 9

NUTRITION

34%

  • f sales

MEDICAL DEVICES

27%

  • f sales

ESTABLISHED PHARMACEUTICALS

16%

  • f sales

DIAGNOSTICS

23%

  • f sales

BROAD AND BALANCED PORTFOLIO

9

slide-10
SLIDE 10

10

UNIQUELY BALANCED FOR GROWTH

Nutrition

  • 45% Emerging; 55% Developed
  • 45% Adult; 55% Pediatric
  • #1 Adult Nutrition globally
  • #1 Pediatric in U.S.; other geographies

STRATEGIC PRIORITIES

  • Capture share with innovation
  • Grow and shape markets
  • Expand operating margin
  • Invest for sustainable growth

Pediatric Adult

13.2% 15.8% 18.7% 21.0%

0% 5% 10% 15% 20% 25%

2011 2012 2013 2014 Operating Margin

slide-11
SLIDE 11

11

RESHAPED FOR GROWTH

Branded Generic Pharmaceuticals Other Emerging Markets Latin America Russia

  • CFR builds presence in Latin America
  • Veropharm builds presence in Russia

STRATEGIC PRIORITIES

  • Strengthening local presence and

capabilities

  • Building locally-relevant portfolios in

key therapeutic areas

India

slide-12
SLIDE 12

12

INNOVATION DRIVING EXPANSION

Medical Devices

Innovation-driven businesses

VASCULAR

  • Driving uptake of MitraClip, Supera

and Absorb DIABETES CARE

  • Highly differentiated FreeStyle Libre

device VISION CARE

  • Winning in Cataract with new products

and market expansion

Vascular Diabetes Care Vision Care

slide-13
SLIDE 13

13

DURABLE GROWTH BUSINESS

Diagnostics Core Laboratory

Molecular Point of Care

  • Leading core lab platforms
  • Leading point-of-care platform
  • Best-in-class molecular tests

STRATEGIC PRIORITIES

  • Execute Commercial Strategy
  • Expand in priority emerging markets
  • Improve margins
  • Launch next-generation platforms
slide-14
SLIDE 14

14

  • Broad and Balanced
  • Leadership
  • Aligned with Trends
  • Top-tier Growth and Income
  • Steady Margin Expansion
  • Strong Cash Flow
  • Increasing Returns to Shareholders

Abbott

GROWTH AND INCOME

slide-15
SLIDE 15